Sriram Ryali

(Mr. Sriram Ryali)

Currently holds a position at Eiger BioPharmaceuticals Inc

Positions

Position Company Period
Chief Financial Officer Eiger BioPharmaceuticals Inc Dec. 3, 2018 -
Sriram Ryali's trades of Caribou Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-30 2025-01-29
B Purchase
17,360 +inf%
1.42
USD 24,651 		17,360 +inf% 1.42 USD 24,651
2023-09-12 2023-09-08
US Codexis Inc (CDXS)
B Purchase
11,650 +10.4%
1.70
USD 19,856 		11,650 +10.4% 1.70 USD 19,856
2022-03-14 2022-03-14
S Sale
2,266 -5.2%
5.60
USD 12,683 		2,266 -5.2% 5.60 USD 12,683
2019-04-22 2019-04-22
B Purchase
1,250 +inf%
11.08
USD 13,853 		1,250 +inf% 11.08 USD 13,853
// ... existing code ... // ... rest of the file ...